On Invalid Date, Chemed (NYSE: CHE) reported Q4 2022 earnings per share (EPS) of $4.17, up 14.37% year over year. Total Chemed earnings for the quarter were $62.13 million. In the same quarter last year, Chemed's earnings per share (EPS) was $4.87.
As of Q1 2023, Chemed's earnings has grown -2.45% year over year. This is 8.9 percentage points higher than the US Medical Care Facilities industry earnings growth rate of -11.35%. Chemed's earnings in the past year totalled $249.62 million.
On Invalid Date, Chemed (NYSE: CHE) reported Q4 2022 revenue of $546.65 million up 1.05% year over year. In the same quarter last year, Chemed's revenue was $540.98 million.
What was CHE's revenue growth in the past year?
As of Q1 2023, Chemed's revenue has grown -0.2% year over year. This is 11.1 percentage points lower than the US Medical Care Facilities industry revenue growth rate of 10.9%. Chemed's revenue in the past year totalled $2.13 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.